Name | N-piperidine Ibrutinib hydrochloride |
---|
Description | N-piperidine Ibrutinib hydrochloride (Compound 1) is a reversible Ibrutinib derivative. N-piperidine Ibrutinib hydrochloride is a potent BTK inhibitor with IC50s of 51.0 and 30.7 nM for WT BTK and C481S BTK, respectively[1]. N-piperidine Ibrutinib hydrochloride can be used as a BTK ligand in the synthesis of a series of PROTACs, such as SJF620 (HY-133137). SJF620 is a potent PROTAC BTK degrader with a DC50 of 7.9 nM[2]. |
---|---|
Related Catalog | |
Target |
IC50: 51.0 nM (WT BTK), 30.7 nM (C481S BTK)[1] |
In Vitro | N-piperidine Ibrutinib hydrochloride can be used as a BTK ligand in the synthesis of a series of PROTACs. SJF638, SJF678, and SJF608 are potent PROTAC BTK degraders with DC50s of 374, 162, and 8.3 nM, respectively[2]. |
References |
Molecular Formula | C22H23ClN6O |
---|---|
Molecular Weight | 422.91 |